Showing 5661-5670 of 21484 results for "".
- GLP-1 Receptor Agonists in ENT Surgery: Expanding Clinical Applicationshttps://reachmd.com/news/glp-1-receptor-agonists-in-ent-surgery-expanding-clinical-applications/2485428/A real-world analysis demonstrates that GLP-1 receptor agonists (GLP-1RAs) are associated with reduced revision surgery and improved disease control in patients wit
- High-Frequency Spinal Cord Stimulation: Revolutionizing Spasticity Managementhttps://reachmd.com/news/high-frequency-spinal-cord-stimulation-revolutionizing-spasticity-management/2485422/High-frequency spinal cord stimulation produced measurable reductions in spasticity and pain in a six‑patient case series, with marked improvements in pain scores and fewer muscle spasms. This si
- Octane Aesthetics Tech Forum: GLP-1 Receptor Agonists Are Reshaping Consumer Behavior and Aesthetic Business Modelshttps://reachmd.com/news/octane-aesthetics-tech-forum-glp-1-receptor-agonists-are-reshaping-consumer-behavior-and-aesthetic-business-models/2485431/The rise of GLP-1 receptor agonist (GLP-1RA) medications is doing more than transforming bodies; it is reshaping the very business of aesthetics. At the 2026 Octane Aesthetics Tech Forum, panelists described how GLP-1RAs are influencing patient behavior, redefining value propositions, and catalyz
- Rehabilitation Strategies for Adolescent Athletes with Spondylolysishttps://reachmd.com/news/rehabilitation-strategies-for-adolescent-athletes-with-spondylolysis/2485406/Adolescent spondylolysis requires a clear rehabilitation plan: timing of physical therapy (PT) influences symptom control and return-to-play for youth athletes. Clinicians therefore face a practical question—when to begin PT to best balance pain relief, functional recovery, and safe sport r
- Rapid Regrowth Tops Treatment Goals for Alopecia Areata: Surveyhttps://reachmd.com/news/rapid-regrowth-tops-treatment-goals-for-alopecia-areata-survey-finds/2485419/Results from a new national survey presented at the 2026 Winter Clinical Dermatology Hawaii reveals that most US clinicians prioritize rapid and nearly complete hair regrowth, with strong satisfaction reported for Janus kinase (JAK) inhibitor therapies.
- Post-COVID Shifts in Pediatric Respiratory Virus Trends and Hospital Admission Predictorshttps://reachmd.com/news/post-covid-shifts-in-pediatric-respiratory-virus-trends-and-hospital-admission-predictors/2485404/A recent study documents a marked post‑COVID surge in influenza and adenovirus among hospitalized children. The cohort shows a clear shif
- Whole-Liver Regional Chemotherapy: A New Era in Hepatobiliary Oncologyhttps://reachmd.com/news/whole-liver-regional-chemotherapy-a-new-era-in-hepatobiliary-oncology/2485416/In a major milestone for cancer care in the region, UT Southwestern Medical Center has become the first institutio
- PRIME Study Findings on Gemini: New Horizons in CKD and AKI Managementhttps://reachmd.com/news/prime-study-findings-on-gemini-new-horizons-in-ckd-and-aki-management/2485413/Revelation Biosciences Inc. is set to unveil promising new clinical data on its investigational therapy, Gemini, during the upcoming
- Advanced Management Strategies in Hepatocellular Carcinomahttps://reachmd.com/news/advanced-management-hepatocellular-carcinoma/2485387/In a retrospective cohort of patients with advanced hepatocellular carcinoma, FOLFOX-based hepatic arterial infusion chemotherapy (HAIC) combined with a
- Analysis: Chronic Hand Eczema Affects 1 in 10 Adultshttps://reachmd.com/news/chronic-hand-eczema-affects-1-in-10-adults-study-finds/2485383/A cross-sectional study of over 10,000 U.S. adults indicates chronic hand eczema (CHE) is more common than previously estimated, with nearly 1 in 10 reporting a physician diagnosis. The data, presented in a poster by Raj Chovati